KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Other Operating Expenses (2016 - 2025)

Precigen (PGEN) has disclosed Other Operating Expenses for 14 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses rose 2.58% to $1.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$123.2 million, a 347.28% decrease, with the full-year FY2024 number at -$92.7 million, down 646.92% from a year prior.
  • Other Operating Expenses was $1.0 million for Q3 2025 at Precigen, down from $5.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $35.6 million in Q2 2024 to a low of -$130.4 million in Q4 2024.
  • A 5-year average of -$5.9 million and a median of $1.5 million in 2023 define the central range for Other Operating Expenses.
  • Biggest YoY gain for Other Operating Expenses was 1995.4% in 2024; the steepest drop was 1169.2% in 2024.
  • Precigen's Other Operating Expenses stood at -$54.9 million in 2021, then soared by 102.29% to $1.3 million in 2022, then skyrocketed by 870.01% to $12.2 million in 2023, then tumbled by 1169.2% to -$130.4 million in 2024, then surged by 100.79% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Other Operating Expenses are $1.0 million (Q3 2025), $5.0 million (Q2 2025), and $1.1 million (Q1 2025).